Citigroup is about to report 2nd-quarter earnings

Citigroup is about to report 2nd-quarter earnings


Crucial Points
  • Citigroup was just this week rebuked for failing to handle its regulatory shortfalls, so analysts will be keen to inquire CEO Jane Fraser about her long-running efforts to tackle the concern.
  • Very last year, Fraser announced strategies to simplify the management composition and lower fees at the 3rd-major U.S. bank by assets.
  • But earnings will just take a backseat if the lender are not able to appease regulators’ fears about its details and threat administration.  



Supply

Stocks making the biggest moves midday: Freeport-McMoran, Coupang, Target & more
Finance

Stocks making the biggest moves midday: Freeport-McMoran, Coupang, Target & more

Check out the companies making the biggest moves midday: Freeport-McMoRan — The miner rose 3.1% as gold and other metals scaled to record levels. Target — The retailer rose more than 1% after The Financial Times reported, citing sources, that hedge fund Toms Capital Investment Management made a big investment in Target. Pressure from the […]

Read More
Stocks making the biggest moves premarket: Nvidia, Micron, SanDisk & more
Finance

Stocks making the biggest moves premarket: Nvidia, Micron, SanDisk & more

Check out the companies making headlines before the bell. Nvidia — The semiconductor firm’s stock rose 0.5% after it agreed to pay $20 billion to acquire assets from artificial intelligence startup Groq, marking its largest purchase ever. Micron Technology , SanDisk — The digital memory firms’ stocks were up after DigiTimes reported , citing industry […]

Read More
Stocks making the biggest moves premarket: Nike, Dynavax Technologies, UiPath & more
Finance

Stocks making the biggest moves premarket: Nike, Dynavax Technologies, UiPath & more

Check out the companies making headlines before the bell: Nike — The sportswear stock rose 2% after a filing showed that Apple CEO Tim Cook bought nearly $3 million worth of Nike shares. Dynavax Technologies — The biopharmaceutical stock surged 38% after Sanofi said it will acquire Dynavax in a deal with a total equity […]

Read More